1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Urticaria Chronic: new trials by email Literature Review of Urticaria Chronic trials Research Report on Urticaria Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria Placebo, 0.5 mg epinephrine, 1 mg epinephrine - Urticaria Chronic | Phase 2 | Recruiting | ARS Pharmaceuticals, Inc. | 42 | 2025-07-09 | 2026-09-16 |
| A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials Briquilimab - Urticaria Chronic | Phase 2 | Terminated | Jasper Therapeutics, Inc. | 67 | 2024-11-26 | 2026-08-06 |
Chronic Urticaria (2) · Pruritus (1)
Chronic Disease (2) · Disease Attributes (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Urticaria (2) · Signs and Symptoms (1) · Skin Manifestations (1)
Epinephrine (1)
ARS Pharmaceuticals, Inc. (1) · Jasper Therapeutics, Inc. (1)
Germany (2) · United States (2)